Press Releases Filter Filter Results Year 2024 (4) 2023 (5) 2022 (23) 2021 (17) 2020 (38) 2019 (36) 2018 (23) 2017 (25) 2016 (20) 2015 (25) 2014 (26) 2013 (31) 2012 (35) April 13, 2018 Abiomed Fourth Quarter Fiscal 2018 Earnings and Conference Call Notification April 4, 2018 Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg April 2, 2018 Abiomed Receives FDA Approval for Impella CP® with SmartAssist™ and Optical Sensor March 30, 2018 Abiomed to Appoint New Chief Financial Officer Todd A. Trapp March 5, 2018 Abiomed Showcases Impella® Technology that Enables Heart Recovery at ACC with 25 Presentations February 14, 2018 Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures February 13, 2018 Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery February 13, 2018 Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock February 1, 2018 Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year January 12, 2018 Abiomed Third Quarter Fiscal 2018 Earnings and Conference Call Notification January 8, 2018 Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154 Million, Up 34% Over Prior Year December 29, 2017 Abiomed to Present at the 36th Annual J.P. Morgan Healthcare Conference October 26, 2017 Abiomed Announces First Patient Treated with Impella® in Japan October 26, 2017 Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33% October 19, 2017 Abiomed's Impella® Technology that Enables Heart Recovery Showcased at TCT 2017 With More Than 30 Presentations … 9 10 11 12 …
